Chair: K.-H. Kuck (Hamburg), C. Nienaber (Rostock)
| (V492) |
Treatment of In-Stent Restenosis and Bifurcation Lesions with Drug-Eluting Stents |
|
|
M. Abdel-Wahab on behalf of DES.DE (Bad Segeberg) |
| (V493) | Drug Eluting Stents in patients with renal insufficiency |
|
|
A. Cuneo (Detmold) |
| (V494) | Outcome after PCI with DES in patients with versus without diabetes mellitus |
|
|
I. Akin (Rostock) |
| (V495) | Cost-effectiveness of Drug-Eluting versus bare-metal stents |
|
|
S. N. Willich (Berlin) |
| (V496) | On- versus Off-Lable-Use of Drug-Eluting Stents |
|
|
T. Bauer (Ludwigshafen) |
| (V497) | Treatment of chronic total occlusions with Drug-Eluting Stents |
|
|
G. S. Werner (Darmstadt) |